HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.

AbstractAIM:
To identify prognostic factors from pretreatment variables of the initial transarterial chemoembolization (TACE) procedure in unresectable hepatocellular carcinoma (HCC).
METHODS:
One thousand and five hundred and sixty-nine patients with unresectable HCC underwent TACE as initial treatment were retrospectively studied. Pretreatment variables of the initial TACE procedure with a P value less than 0.05 by univariate analysis were subjected to Cox proportional hazards model.
RESULTS:
The median overall survival time and 1-, 5-, 10-year survival rates were 10.37 mo, 47%, 10%, and 7%, respectively. A Cox proportional hazard model showed that 8 pretreatment factors of regional lymph nodes metastasis, Child-Pugh class, macrovascular invasion, greatest dimension, alpha-fetoprotein (AFP), Hepatitis virus B, tumor capsule, and nodules were independent prognostic factors. Patients with multimodality therapy have better survival than those with TACE treatment only.
CONCLUSION:
Tumor status, hepatic function reserve, AFP, and hepatitis virus B status were independent prognostic factors for unresectable HCC. Distant metastasis might not be a contraindication to TACE. Multimodality therapy might improve survival.
AuthorsMing Shi, Ji-An Chen, Xiao-Jun Lin, Rong-Ping Guo, Yun-Fei Yuan, Min-Shan Chen, Ya-Qi Zhang, Jin-Qing Li
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 16 Issue 2 Pg. 264-9 (Jan 14 2010) ISSN: 2219-2840 [Electronic] United States
PMID20066748 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • alpha-Fetoproteins
Topics
  • Adult
  • Carcinoma, Hepatocellular (diagnosis, epidemiology, therapy)
  • Chemoembolization, Therapeutic
  • China (epidemiology)
  • Female
  • Hepatitis B virus (isolation & purification)
  • Humans
  • Liver (physiopathology)
  • Liver Neoplasms (diagnosis, epidemiology, therapy)
  • Male
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: